Displaying results 1-10 of 89

• ASBMB Today Article
  ‘We're all a bunch of weirdos doing our stuff’
  May 20, 2022
  

  An interview with Charles Sanders, a research associate at XBiotech.
• ASBMB Today Article
  How Robert Langer, a pioneer in delivering mRNA into the body, failed repeatedly but kept going
  May 3, 2022
  

  "They said I should give up, but I don’t like to give up," the pioneer in delivering mRNA to the body said.
• ASBMB Today Article
  'Anywhere you go, be ready to review your work'
  April 29, 2022
  

  Maria Grandoni is a scientist at PPD. She talked to our industry careers columnist about her work on the manufacturing and quality side of industry.
• ASBMB Today Article
  Ole Miss strikes $5M deal with company warned for claiming essential oils can cure COVID
  April 26, 2022
  

  Companies have long sought to partner on research with public universities, which, starved for state funding, eagerly take private dollars.
• ASBMB Today Article
  ‘Have faith in that training’
  March 18, 2022
  

  Raghuvir Sengupta has been a biochemist for HP and is now a Pfizer postdoc. He talks about his work and how his graduate training prepared him for his industry career.
• ASBMB Today Article
  90% of drugs fail clinical trials
  March 12, 2022
  

  Here’s one way researchers can select better drug candidates.
• ASBMB Today Article
  Inside the tactical tug of war over the controversial Alzheimer’s drug
  March 5, 2022
  

  The drug, Aduhelm, with a listed price tag of $28,200 a year, has had few takers in the medical world.
• ASBMB Today Article
  'A different career almost every three years'
  Feb. 25, 2022
  

  Christian Cunningham traces his path from washing dishes at Berkeley to discovering drugs at Genentech.
• ASBMB Today Article
  Society news briefs: February 2022
  Feb. 14, 2022
  

  Find out everything that’s been going on at the American Society for Biochemistry and Molecular Biology.
• ASBMB Today Article
  ‘A holistic view’
  Feb. 4, 2022
  

  As a metabolomics application specialist, Heino Heyman gets to talk metabolomics all day, helping customers plan and analyze their studies.